Study end-pointsThe primary end-point of the study was change in bodyweight in kilograms in both groups at 3 months followup. Secondary end-points included change in bodyweight derivatives: waist circumference and BMI, resting HR, SBP/DBP, TC and glucose at 3 months as wellas clinical outcomes including hospitalizations, ambulatory visits, reported symptoms and changes in medication reported during follow-up visit.